ESC 365 - Controversies in ICD therapy: the subcutaneous defibrillator is superior to the transvenous defibrillator - rebuttal & discussion

EHRA Premium Access

Controversies in ICD therapy: the subcutaneous defibrillator is superior to the transvenous defibrillator - rebuttal & discussion

Session: Pacemakers and ICDs: controversies in device therapy

Topic: Device Therapy

Event: EHRA 2021

Congress Presentation

Add to my library

5 more presentations in this session

Controversies in cardiac stimulation: conduction system pacing is superior to conventional pacing - pro

Speaker: Associate Professor G. Upadhyay (Chicago, US)

Controversies in cardiac stimulation: conduction system pacing is superior to conventional pacing - con

Speaker: Professor M. Glikson (Jerusalem, IL)

Controversies in cardiac stimulation: conduction system pacing is superior to conventional pacing- rebuttal & discussion

Controversies in ICD therapy: the subcutaneous defibrillator is superior to the transvenous defibrillator - pro

Speaker: Miss L. Timmers (Ghent, BE)

Controversies in ICD therapy: the subcutaneous defibrillator is superior to the transvenous defibrillator - con

Speaker: Professor H. Burri (Geneva, CH)

Access the full session

Pacemakers and ICDs: controversies in device therapy

Speakers: Associate Professor G. Upadhyay, Professor M. Glikson, Miss L. Timmers, Professor H. Burri

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources